193 related articles for article (PubMed ID: 37603945)
1. Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer.
Adewunmi O; Shen Y; Zhang XH; Rosen JM
Cancer Immunol Res; 2023 Nov; 11(11):1462-1479. PubMed ID: 37603945
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.
Jin C; Yan B; Lu Q; Lin Y; Ma L
Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637
[TBL] [Abstract][Full Text] [Related]
4. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer.
Singh S; Lee N; Pedroza DA; Bado IL; Hamor C; Zhang L; Aguirre S; Hu J; Shen Y; Xu Y; Gao Y; Zhao N; Chen SH; Wan YW; Liu Z; Chang JT; Hollern D; Perou CM; Zhang XHF; Rosen JM
Cancer Res; 2022 Jun; 82(12):2281-2297. PubMed ID: 35442423
[TBL] [Abstract][Full Text] [Related]
6. [JAG1 affects monocytes-macrophages to reshape the pre-metastatic niche of triple-negative breast cancer through LncRNA MALAT1 in exosomes].
Xu M; Shi Y; Liu J; Wu M; Zhang F; He Z; Tang M
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1525-1535. PubMed ID: 37814867
[TBL] [Abstract][Full Text] [Related]
7. ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer.
Wang G; Romero Y; Thevarajan I; Zolkiewska A
Oncoimmunology; 2023; 12(1):2158006. PubMed ID: 36545255
[TBL] [Abstract][Full Text] [Related]
8. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
9. Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.
Brock M; Schuoler C; Leuenberger C; Bühlmann C; Haider TJ; Vogel J; Ulrich S; Gassmann M; Kohler M; Huber LC
Exp Biol Med (Maywood); 2017 Mar; 242(5):487-496. PubMed ID: 28056547
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss.
Arun G; Diermeier S; Akerman M; Chang KC; Wilkinson JE; Hearn S; Kim Y; MacLeod AR; Krainer AR; Norton L; Brogi E; Egeblad M; Spector DL
Genes Dev; 2016 Jan; 30(1):34-51. PubMed ID: 26701265
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
Mao TL; Fan MH; Dlamini N; Liu CL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.
Li Y; Liu YD; Chen SL; Chen X; Ye DS; Zhou XY; Zhe J; Zhang J
Mol Hum Reprod; 2019 Jan; 25(1):17-29. PubMed ID: 30371869
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model.
Parveen S; Siddharth S; Cheung LS; Kumar A; Shen J; Murphy JR; Sharma D; Bishai WR
Mol Oncol; 2021 May; 15(5):1330-1344. PubMed ID: 33682324
[TBL] [Abstract][Full Text] [Related]
15. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Yamashita N; Long M; Fushimi A; Yamamoto M; Hata T; Hagiwara M; Bhattacharya A; Hu Q; Wong KK; Liu S; Kufe D
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495298
[TBL] [Abstract][Full Text] [Related]
16. Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
Lal JC; Townsend MG; Mehta AK; Oliwa M; Miller E; Sotayo A; Cheney E; Mittendorf EA; Letai A; Guerriero JL
Breast Cancer Res; 2021 Aug; 23(1):83. PubMed ID: 34353349
[TBL] [Abstract][Full Text] [Related]
17. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis by Targeting miR-124 in Retinoblastoma.
Liu S; Yan G; Zhang J; Yu L
Oncol Res; 2018 May; 26(4):581-591. PubMed ID: 28550678
[TBL] [Abstract][Full Text] [Related]
19. A cutting-edge immunomodulatory interlinkage between HOTAIR and MALAT1 in tumor-associated macrophages in breast cancer: A personalized immunotherapeutic approach.
Amer HT; Eissa RA; El Tayebi HM
Front Mol Biosci; 2022; 9():1032517. PubMed ID: 36387279
[TBL] [Abstract][Full Text] [Related]
20. A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis.
Hu Y; He Y; Luo N; Li X; Guo L; Zhang K
Cancer Biol Ther; 2023 Dec; 24(1):2235768. PubMed ID: 37548553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]